Trial intelligence / Profile preview

Human Treated Dentin Matrix for Apexogenesis in Young Permanent Molars

NCT05830695Phase 2Completed

Start
Jan 2022
Primary completion
Jul 2022
Countries
1
01

Overview

Phase 2, randomised, open-label trial in dental caries (2 arms). Primary endpoints: Clinical Outcome at 18 months, Radiographic Outcomes at 18 months and 1 more. Started Jan 2022; status: completed.

02

Conditions

dental caries

Beyond the preview

Go deeper on NCT05830695.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05830695.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call